Position in MRK
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,284,871
+$88,828 QoQ
Shares Held
9,999
+0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
#1,920
of 3,769 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Family Capital Management, Inc. holds $6,119,827 across 8 Drug Manufacturers - General names. MRK ranks #1 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
9,999 | $1,284,871 | |
| 2 | LLY |
ELI LILLY & Co
|
865 | $1,037,507 | |
| 3 | JNJ |
Johnson & Johnson
|
3,699 | $939,435 | |
| 4 | ABBV |
AbbVie Inc.
|
3,529 | $888,037 | |
| 5 | PFE |
Pfizer Inc
|
28,226 | $679,682 | |
| 6 | AZN |
Astrazeneca PLC
|
2,926 | $554,828 | |
| 7 | NVS |
Novartis AG
|
3,309 | $518,586 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,764 | $216,881 |
All Filings in MRK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,284,871 | 9,999 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,196,043 | 9,943 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,277,961 | 12,141 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $898,806 | 10,709 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $704,603 | 8,901 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $339,203 | 3,779 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $262,527 | 2,639 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $236,999 | 2,087 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $255,399 | 2,063 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $264,823 | 2,007 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $207,247 | 1,901 | Shares | Sole | 2024-01-31 | |
| No filing history on record for this holder in this stock. | ||||||